HC Wainwright & Co. Reiterates Buy on Evolus, Maintains $13 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.3%

Neg 0% Neu 88.3% Pos 0%

HC Wainwright & Co. analyst Douglas Tsao reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $13 price target.

Comments

No comments yet. Be the first!